A
Aaron Polliack
Researcher at Hebrew University of Jerusalem
Publications - 198
Citations - 5853
Aaron Polliack is an academic researcher from Hebrew University of Jerusalem. The author has contributed to research in topics: Chronic lymphocytic leukemia & Leukemia. The author has an hindex of 36, co-authored 190 publications receiving 5254 citations. Previous affiliations of Aaron Polliack include Hadassah Medical Center & Tel Aviv Sourasky Medical Center.
Papers
More filters
Journal ArticleDOI
Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia
Jan A. Burger,Alessandra Tedeschi,Paul M. Barr,Tadeusz Robak,Carolyn Owen,Paolo Ghia,Osnat Bairey,Peter Hillmen,Nancy L. Bartlett,Jianyong Li,David Simpson,Sebastian Grosicki,Stephen Devereux,Helen McCarthy,Steven Coutre,Hang Quach,Gianluca Gaidano,Zvenyslava Maslyak,Don A. Stevens,Ann Janssens,Fritz Offner,Jiří Mayer,Michael O'Dwyer,Andrzej Hellmann,Anna Schuh,Tanya Siddiqi,Aaron Polliack,Constantine S. Tam,Deepali Suri,Mei Cheng,Fong Clow,Lori Styles,Danelle F. James,Thomas J. Kipps +33 more
TL;DR: Ibrutinib was superior to chlorambucil in previously untreated patients with CLL or small lymphocytic lymphoma, as assessed by progression-free survival, overall survival, response rate, and improvement in hematologic variables.
Journal ArticleDOI
Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia
Eva Klein,Farkas Vánky,Hannah Ben-Bassat,Hava Neumann,Peter Ralph,Jesper Zeuthen,Aaron Polliack +6 more
TL;DR: The K562 cell line derived from a CML patient in blast crisis was examined for properties of B and T lymphocytes and cell lines, and some of its characteristics indicate that it is probably not lymphoid.
Journal ArticleDOI
Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern.
TL;DR: Functional and tissue distribution differences of Livin α and β suggest that Livin may play a complex role in the regulation of apoptosis.
Journal ArticleDOI
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia
Michael R. Grever,Omar Abdel-Wahab,Leslie A. Andritsos,Versha Banerji,Jacqueline C. Barrientos,James S. Blachly,Timothy G. Call,Daniel Catovsky,Claire Dearden,Judit Demeter,Monica Else,Francesco Forconi,Alessandro Gozzetti,Anthony D. Ho,James B. Johnston,Jeffrey A. Jones,Gunnar Juliusson,Eric H. Kraut,Robert J. Kreitman,Loree Larratt,Francesco Lauria,Gerard Lozanski,Emili Montserrat,Sameer A. Parikh,Jae-Hyun Park,Aaron Polliack,Graeme R. Quest,Kanti R. Rai,Farhad Ravandi,Tadeusz Robak,Alan Saven,John F. Seymour,Tamar Tadmor,Martin S. Tallman,Constantine S. Tam,Enrico Tiacci,Xavier Troussard,Clive S. Zent,Thorsten Zenz,Pier Luigi Zinzani,Brunangelo Falini +40 more
TL;DR: The development of consensus guidelines for this disease offers a framework for continued enhancement of the outcome for patients, and organized evaluations of minimal residual disease and treatment at relapse offer ample opportunities for clinical research.
Journal ArticleDOI
Suppressive effect of ferritin on in vitro lymphocyte function.
TL;DR: Ferritin suppresses certain parameters of T‐lymphocyte function in vitro, and the relation of the present findings to recognized abnormalities of T-cell function encountered in certain neoplastic disorders associated with high serum ferritin levels is at present unknown.